Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Veiseh O et al. – With the versatile affinity of the targeting ligand and the flexible conjugation chemistry for alternative diagnostic and therapeutic agents, this nanoparticle platform can be potentially used for the diagnosis and treatment of a variety of tumor types.

Related Articles

Brain Tumor Survivors Speak Out
Journal of Pediatric Oncology Nursing, 10/26/09    Relevance Score: 70%

Immunotherapy of pediatric brain tumor patients should include an immunoprevention strategy: a medical hypothesis paper
Journal of Neuro-Oncology, 10/26/09    Relevance Score: 70%

Endocrine Late Effects in Survivors of Pediatric Brain Tumors
Journal of Pediatric Oncology Nursing, 10/26/09    Relevance Score: 69%

Convection-enhanced delivery for the treatment of brain tumors
Expert Review of Neurotherapeutics, 10/21/09    Relevance Score: 69%

Assessment of total sialic acid and lipid-bound sialic acid in management of brain tumors
Annals of the Indian Academy of Neurology, 10/16/09    Relevance Score: 69%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address